1. Dusek L, et al. Epidemiology, prevention and treatment of Colorectal cancer based on available studies and data. Prague: University Hospital Motol;2012.
2. Majek O, Danes J, Zavoral M, et al. Czech National Cancer Screening Programmes in 2010. Klinická Onkologie, 2010;23(5):343–53.
3. Majek O, Danes J, Skovajsova M, et al. Breast cancer screening in the Czech Republic: time trends in performance indicators during the first seven years of the organised programme. BMC Public Health, 2011;11:288.
4. Zavoral M, Suchanek S, Zavada F, et al. Colorectal cancer screening in Europe. World Journal of Gastroenterology, 2009;15(47):5907–5915.
5. Kral N, Seifert B. Změny ve screeningu kolorektálního karcinomu - krok správným směrem? Onkologie, 2010;4(4):251–255.
6. Vernon SW, Meissner H, Klabunde C, et al. Measures for ascertaining use of colorectal cancer screening in behavioral, health services, and epidemiologic research. Cancer Epidemiology Biomarkers Prevention, 2004;13(6):898–905.
7. Jepson R, Clegg A, Forbes C, et al. The determinants of screening uptake and interventions for increasing uptake: a systematic review. Health Technol Assess, 2000;4(14):1–133.
8. Wardle J, Sutton S, Williamson S, et al. Psychosocial influences on older adults‘ interest in participating in bowel cancer screening. Prev Med, 2000;31(4):323–334.
9. Hudson SV, Ohman-Strickland P, Cunningham R, et al. The effects of teamwork and system support on colorectal cancer screening in primary care practices. Cancer Detect Prev, 2007;31(5):417–423.
10. Lawsin C, DuHamel K, Itzkowitz SH, et al. Demographic, medical, and psychosocial correlates to CAM use among survivors of colorectal cancer. Support Care Cancer, 2007;15(5):557–564.
11. European Colorectal Cancer Screening Guidelines Working Group, European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy, 2013;45(1):51–59.
12. Denters M, Deutekom M, Fockens P, et al. Implementation of population screening for colorectal cancer by repeated fecal occult blood test in the Netherlands. BMC Gastroenterology, 2009;9:28.
13. Berchi C, Guittet L, Bouvier V, et al. Cost-effectiveness analysis of the optimal threshold of an automated immunochemical test for colorectal cancer screening: performances of immunochemical colorectal cancer screening. Int J Technol Assess Health Care, 2010;26(1):48–53.
14. Colonoscopy and colorectal cancer screening strategies. Committee Opinion No 482. American College of Obstetricians and gynecologists. Obstet Gyencol, 2011;117:766–771.
15. Kuipers EJ, Rösch T, Bretthauer M, et al. Colorectal cancer screening-optimizing current strategies and new directions. Nat Rev Clin Oncol, 2013;10(3):130–142.
16. Zavoral M, Fric P, Suchanek S, et al. National screening program for sporadic colorectal cancer: Development, Present and Perspective, Health News. Gastroenterology, 2013;16–19.
17. Skovajsova M, et al. Screening of breast carcinoma screening in the Czech Republic requires cooperation with surgeons. Rozhl Chir, 2012;91(3):121–131.
18. Menees SB, Patel DA, Dalton V, et al. Colorectal cancer screening practices among obstetrician/gynecologists and nurse practitioners. J Womens Health, 2009;18(8):1233–1238.
19. Gregory, et al. Demographic, social cognitive and social ecological predictors of intention and participation in screening for colorectal cancer. BMC Public Health, 2011;11–38.
20. Menees SB, Inadomi J, Elta G, et al. Colorectal Cancer Screening Compliance and Contemplation in Gynecology Patients, JWH, 2010;911–916.
21. Frederiksen BL, Jørgensen T, Brasso K, et al. Socioeconomic position and participation in colorectal cancer screening. Br J Cancer, 2010;103(10):1496–1501.
22. Bae N, Park S, Lim S, et al. Factors associated with adherence to fecal occult blood testing for colorectal cancer screening among adults in the Republic of Korea. Eur J Oncol Nurs, 2014;18(1):72–77.
23. Bapuji S, Lobchuk M, McClement S, et al. Fecal occult blood testing instructions and impact on patient adherence. Cancer Epidemiol, 2012;36(4):e258–264.
24. Fiscella K, Yosha A, Hendren S, et al. Get screened: a pragmatic randomized controlled trial to increase mammography and colorectal cancer screening in a large, safety net practice. BMC Health Serv Res, 2010;10:280.
25. Lobchuk M, Bapuji S, McClement S, et al. What is the role of family in promoting faecal occult blood test screening? Exploring physician, average-risk individual, and family perceptions. Cancer Epidemiol, 2012;36(3):190–199.
26. Zauber A, Lansdorp-Vogelaar I, Knudsen A, et al. Evaluating Test Strategies for Colorectal Cancer Screening – Age to Begin, Age to Stop, and Timing of Screening Intervals: A Decision Analysis of Colorectal Cancer Screening for the U.S. Preventive Services Task Force from the Cancer Intervention and Surveillance Modeling. Rockville: USA;2009.
27. Viguier J, Calazel-Benque A, Eisinger F, et al. Organized colorectal cancer screeing programmes: how to optimize efficiency among general practitioners. European Jounal of Cancer Prevention, 2011;20 Suppl 1:S26–32.
28. Worthley D, Cole S, Esterman A, et al. Screening for colorectal cancer by faecal occult blood test: why people choose to refuse. Intern Med J, 2006;36(9):607–610.
29. Lo S, Waller J, Wardle J, et al. Comparing barriers to colorectal cancer screening with barriers to breast and cervical screening: a population-based survey of screening-age women in Great Britain. J Med Screen, 2013;20(2):73–79.
30. Debarros M, Steele S, et al. Colorectal cancer screening in an equal access healthcare system. J Cancer, 2013;4(3):270–280.
31. Tastan S, Andsoy I, Iyigun E, et al. Evaluation of the knowledge, behavior and health beliefs of individuals over 50 regarding colorectal cancer screening. Asian Pac J Cancer Prev, 2013;14(9):5157–5163.
32. Haggstrom D, Klabunde C, Smith J, et al. Variation in primary care physicians‘ colorectal cancer screening recommendations by patient age and comorbidity. J Gen Intern Med, 2013;28(1):18–24.
33. Dreier M, Borutta B, Seidel G, et al. Leaflets and websites on colorectal cancer screening and their quality assessment from experts’ views. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 2014;57(3):356–365.
34. Fortuna R, Idris A, Winters P, et al. Get Screened: A Randomized Trial of the Incremental Benefits of Reminders, Recall, and Outreach on Cancer Screening. J Gen Intern Med, 2014;29(1):90–97.
35. Tinmouth J, Ritvo P, McGregor S, et al. ColonCancerCheck Primary Care Invitation Pilot project: family physician perceptions. Can Fam Physician, 2012;58(10):e570–577.
36. Liss D, Petit-Homme A, Feinglass J, et al. Adherence to repeat fecal occult blood testing in an urban community health center network. J Community Health, 2013;38(5):829–833.
37. Centers for Disease Control and Prevention (CDC). Vital signs: colorectal cancer screening test use – United States, Morb Mortal Wkly Rep, 2013;8;62(44):881–888.
38. Charters T, Strumpf E, Sewitch M, et al. Effectiveness of an organized colorectal cancer screening program on increasing adherence in asymptomatic average-risk Canadians. BMC Health Serv Res, 2013;13:449.
39. Aarts M, Lemmens V, Louwman M, et al. Socioeconomic status and changing inequalities in colorectal cancer? A review of the associations with risk, treatment and outcome. Eur J Cancer, 2010;46(15):2681–2695.
40. Ferrat E, Le Breton J, Veerabudun K, et al. Colorectal cancer screening: factors associated with colonoscopy after a positive faecal occult blood test. Br J Cancer, 2013;109(6):1437–444.
41. Van Agt H, Korfage I, Essink-Bot M, et al. Interventions to enhance informed choices among invitees of screening programmes – a systematic review. Eur J Public Health, 2014, published online.
42. Cole S, Young G, Byrne D, et al. Participation in screening for colorectal cancer based on a faecal occult blood test is improved by endorsement by the primary care practitioner. J Med Screen, 2002;9(4):147–152.
43. Tinmouth J, Ritvo P, McGregor E, et al. A qualitative evaluation of strategies to increase colorectal cancer screening uptake. Can Fam Physician. 2011;57(1): e7–e15.
44. Weller D, Coleman D, Robertson R, et al. The UK colorectal cancer screening pilot: results of the second round of screening in England. 2007;97(12):1601–1605.
45. Denters M, Deutekom M, Bossuyt P, et al. Involvement of previous non-participants cannot fully compensate for lower participation in a second round of FIT-screening. Cancer Epidemiol, 2013;37(3):330–335.
46. Haack G, Köster M, Töppich J, et al. Information on early detection of colorectal cancer : Development of an information module for the Women‘s Health Portal of the Federal Center for Health Education (BZgA). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 2014;57(3):380–387.
47. Huang J, Shi L, et al. Differences in behavioral outcomes between first-year and second-year participants in a community-based colorectal cancer education intervention. Asian Pac J Cancer Prev, 2011;12(12):3323–3329.
48. Clouston K, Katz A, Martens P, et al. CIHR/CCMB Team in Primary Care Oncology (PCO-NET). Does access to a colorectal cancer screening website and/or a nurse-managed telephone help line provided to patients by their family physician increase fecal occult blood test uptake?: A pragmatic cluster randomized controlled trial study protocol. BMC Cancer, 2012;12:182.
49. Seeff L, Nadel M, Klabunde C, et al. Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer, 2004;100(10):2093–2103.
50. Cogbill S, Francis B, Thompson V, et al. Factors Affecting African American Men’s Use of Online Colorectal Cancer Education. J Cancer Educ, 2014;29(1):25–29.
51. Smith S, Blumenthal D et al. Efficacy to effectiveness transition of an Educational Program to Increase Colorectal Cancer Screening (EPICS): study protocol of a cluster randomized controlled trial. Implement Sci, 2013;8:86.
52. Brawarsky, P, Brooks D, Mucci, et al. Effect of physician recommendation and patient adherence on rates of colorectal cancer testing. Cancer Detection and Prevention, 2004;28(4):260–268.
53. Senore C, Malila N, Minozzi S, et al. How to enhance physician and public acceptance and utilisation of colon cancer screening recommendations. Best Pract Res Clin Gastroenterol, 2010;24(4):509–520.